CNW Stock Overview
co.don AG, a biopharmaceutical company, develops, produces, and markets biopharmaceutical products for joint preservation and the regenerative treatment of articular cartilage defects worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
co.don AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.24 |
| 52 Week High | €1.93 |
| 52 Week Low | €0.24 |
| Beta | 1.46 |
| 1 Month Change | 0% |
| 3 Month Change | -28.99% |
| 1 Year Change | -84.49% |
| 3 Year Change | -93.45% |
| 5 Year Change | -98.48% |
| Change since IPO | -99.60% |
Recent News & Updates
Recent updates
Here's Why co.don (ETR:CNW) Can Afford Some Debt
Oct 06
Health Check: How Prudently Does co.don (ETR:CNWK) Use Debt?
May 06Will co.don (ETR:CNWK) Spend Its Cash Wisely?
Mar 15Analysts Expect Breakeven For co.don AG (ETR:CNWK) Before Long
Feb 08co.don's(ETR:CNWK) Share Price Is Down 85% Over The Past Three Years.
Jan 04
Shareholder Returns
| CNW | DE Biotechs | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.8% | -0.03% |
| 1Y | -84.5% | 38.7% | 5.5% |
Rendite im Vergleich zur Industrie: CNW unter dem Niveau der Branche German Biotechs , die im vergangenen Jahr eine Rendite von -23.4% erzielte.
Rendite vs. Markt: CNW hinter dem Markt German zurück, der im vergangenen Jahr eine Rendite von 4.7 erzielte.
Price Volatility
| CNW volatility | |
|---|---|
| CNW Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 5.4% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.1% |
| 10% least volatile stocks in DE Market | 2.4% |
Stabiler Aktienkurs: CNWDer Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.
Volatilität im Zeitverlauf: Unzureichende Daten, um die Volatilitätsveränderung von CNW im vergangenen Jahr zu bestimmen.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 134 | Tilmann Bur | https://www.codon.de |
co.don AG Fundamentals Summary
| CNW fundamental statistics | |
|---|---|
| Market cap | €6.55m |
| Earnings (TTM) | -€14.12m |
| Revenue (TTM) | €9.84m |
0.7x
P/S Ratio-0.5x
P/E RatioIs CNW overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNW income statement (TTM) | |
|---|---|
| Revenue | €9.84m |
| Cost of Revenue | €1.88m |
| Gross Profit | €7.96m |
| Other Expenses | €22.09m |
| Earnings | -€14.12m |
Last Reported Earnings
Jun 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.53 |
| Gross Margin | 80.89% |
| Net Profit Margin | -143.55% |
| Debt/Equity Ratio | 64.1% |
How did CNW perform over the long term?
See historical performance and comparison